AGER and pulmonary fibrosis: In the old groups, it was suggested that complement and coagulation cascades, neuroactive ligand−receptor interactions, and the PI3K−Akt, AGE-RAGE, cell cycle, and drug metabolism−cytochrome P450 pathways were involved in pulmonary fibrosis.